Skip to main content
  1. Modern Diagnostic & Research Centre
Modern Diagnostic & Research Centre
374.47xsubscribed

Modern Diagnostic & Research Centre

Hospital & Healthcare Services
listed
₹2.72LMin. investment

Modern Diagnostic & Research Centre IPO Details

SectorHospital & Healthcare Services
Price range₹85.00 – ₹90.00
IPO type
SME
Lot size1600 shares
Issue size₹37Cr
Draft Red Herring Prospectus
Read
Market cap
₹135.89CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹77.94CrLower than sector avg
Growth rate3Y CAGR
17.69%

Modern Diagnostic & Research Centre Subscription Status

Date
QIB
NII
Retail
Total
31-Dec-25
0.05 times (X)
3.44 times (X)
0.0 times (X)
5.89 times (X)
01-Jan-26
0.84X
52.28X
33.85X
30.91X
02-Jan-26
9.9X
686.91X
338.44X
374.47X

As on 31-Dec-25, 5:30 PM

Modern Diagnostic & Research Centre Timeline

  1. Pre-apply
    30 Dec 2025
  2. Bid start
    31 Dec 2025
  3. Bid end
    2 Jan 2026
  4. Allotment
    5 Jan 2026
  5. Release of funds
    6 Jan 2026
  6. Demat transfer
    6 Jan 2026
  7. Listing
    7 Jan 2026

About Modern Diagnostic & Research Centre

Modern Diagnostic & Research Centre is a service provider in diagnostic and related healthcare tests in India. The company delivers diagnostic services that include core testing, disease diagnosis, prevention, and monitoring for individual patients, hospitals, healthcare providers, and corporate clients. The company offers services through pathology and clinical laboratories, as well as imaging services like ultrasound, colour Doppler, CT scan, MRI scan, digital X-ray, mammography, ECG, PFT, and other specialised diagnostic tests. Currently, it operates 21 centres, which consist of 18 laboratories and three diagnostic centres across 8 states with advanced tech like 3T MRI, 128-slice CT, NGS, and PACS for digital imaging. It also provides additional services, such as online access to test reports, home sample collection, and customised test packages for both individual and institutional clients.
As of June 30, 2025, Pathology made up 80.70% of revenue from operations, while radiology made up 19.30%. Domestic revenue was mainly from Haryana, which contributed 65.80%. India accounted for 96.70% of the revenue, and the remainder came from various countries such as Kenya, Nepal, Ethiopia, Uganda, and Dubai. In FY25, it conducted 3.24 crore tests for 13.69 lakh patients, with B2C revenues forming 48.66% and B2B 51.34%.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Modern Diagnostic And Research Centre IPO

Capital expenditure
55.80%
The company will utilise ₹20.68 crore for the purchase of medical equipment for diagnostic centres
Working capital
21.60%
The company will utilise ₹8 crore towards funding working capital requirements
General corporate purposes
19.90%
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Repayment of borrowings
2.70%
The company will utilise ₹1 crore to repay certain outstanding borrowings

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹77.94Cr17.69%₹8.96Cr₹135.89Cr11.041.07
This sector (avg.)₹810.55Cr---₹87.66Cr₹10,075.9Cr55.140.40
₹21,794Cr---₹1,472.1Cr₹1,00,081.3Cr59.860.96
₹7,028.46Cr---₹1,075.88Cr₹93,096.78Cr68.940.32
₹7,782.75Cr---₹809.39Cr₹64,284.69Cr63.430.28

*Revenue for financial year 2024-25. Lower P/E and D/E ratios are generally preferred.

Modern Diagnostic & Research Centre Contact Details

Company NameModern Diagnostic & Research Centre

How to apply for Modern Diagnostic & Research Centre?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Modern Diagnostic And Research Centre IPO FAQs

Investors can apply for the Modern Diagnostic & Research Centre through their Demat account via the stock exchange or through their broker.
The issue size of the Modern Diagnostic & Research Centre is 37 Cr.
Pre-applying for an IPO allows you to submit your application before the official subscription period begins.
The IPO shares will typically list on major stock exchanges such as the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE), as specified in the IPO prospectus.
Modern Diagnostic & Research Centre will be open between 2025-12-31 and 2026-01-02.
Modern Diagnostic & Research Centre allotment date is 2026-01-06. For Modern Diagnostic & Research Centre allotment status check, you can visit the website of the registrar of the IPO.
For Modern Diagnostic & Research Centre, the IPO registrar is MUFG Intime India Pvt.Ltd.. You can check Modern Diagnostic & Research Centre allotment status on the website of the registrar.
The shares are proposed to be listed on the BSE and NSE.
The Modern Diagnostic & Research Centre shares will typically be credited to your demat account one working day before the IPO's listing date, provided your application is successfully allotted.
The Modern Diagnostic & Research Centre lot size is 1600 and minimum order quantity is 3200.
Modern Diagnostic & Research Centre has set the price band for its IPO at 90 per equity share with a face value of 10.